March 24, 2023 Abstract Despite a growing number of effective therapeutic options for patients with pancreatic adenocarcinoma, the prognosis remains dismal mostly due to the late-stage presentation and spread of the cancer to other organs. Because a genomic analysis of… Read More
February 2nd, 2023 SCOTTSDALE, AZ — Imaging Endpoints (IE), the world’s largest oncology-focused imaging CRO, announced today the addition of Steven P. Rowe, M.D., Ph.D., to the company’s Scientific Advisory Board (SAB). Dr. Rowe is an Associate Professor of Radiology… Read More
November 16, 2022 SCOTTSDALE, AZ — Imaging Endpoints (IE), the world’s largest oncology-focused imaging CRO, announced today the addition of Joy (Huan) Zhu, M.D., Ph.D., to the company as Vice President, Medical Operations. Prior to joining IE, Joy spent 25… Read More
This is an excerpt from our white paper, “Tumor Growth Kinetic Modeling.” To access the full white paper, click here. UNDERSTANDING TUMOR GROWTH KINETICS Estimating the changes in tumor burden that an individual or cohort of patients experience during treatment… Read More
Esteemed oncologist to advise on imaging efforts Sept. 7, 2022 SCOTTSDALE, Ariz.--Imaging Endpoints (IE) announced today that Dr. Antonio Tito Fojo was chosen to join their Scientific Advisory Board, a global group of leading medical professionals appointed to provide strategic… Read More
This is an excerpt from our white paper, “Using PCWG3 Classification in Prostate Cancer.” To access the full white paper, click here. HISTORICAL OVERVIEW OF PROSTATE CANCER CLINICAL TRIALS WORKING GROUPThe initial criterion for prostate cancer evaluation in clinical trials… Read More
This is an excerpt from our free eBook, "The RANO Criteria and Keeping Pace with Discovery." To access the full eBook, click here. LESION MEASUREMENT Lesion measurement is often challenging when implementing the RANO criteria. This is due to the… Read More
Global Growth to Connect Imaging to the Cure Driving Impactful Regulatory Approvals and Expansion Imaging Endpoints (IE), based in Scottsdale Arizona with eight offices in six countries, announced today the promotion of Jatinder Kaur to Chief Operating Officer (COO). Jatinder… Read More
This is an excerpt from our free eBook, “Using 18FDG-PET and Other PET Agents in Oncology Clinical Trials.” To access the full eBook, click here. THE USE OF PET IN ONCOLOGY CLINICAL TRIALS 18F FDG PET Imaging in Solid Tumors… Read More
This is an excerpt from our free eBook, "Response Assessment in Lymphoma: The Lugano Classification and Beyond." To access the full eBook, click here. STANDARDIZING THE EVALUATION OF LYMPHOMA: HISTORICAL OVERVIEW Although Cheson 2007 criteria made significant improvements over the… Read More
Featured Webinar:
Radiologic Analysis of COVID-19 Infection
June 23, 2020
